Microsoft and Adaptive Biotechnologies launch new study to decode immune response to COVID-19 May 5, 2020 by admin Tweet The two firms are expanding their partnership by introducing a new virtual clinical study which will attempt to discover improved diagnostics by observing 1000 participants affected by COVID-19. Read more… Neowin Related Posts:Apple's COVID-19 Response Team lets employees…New study says NHS contact tracing app was very effectiveChina locks down one million people near iPhone…COVID-19 causes further delay for Googlers' return to workCovid-19 lockdown slows down chip manufacturing in China
